The Baker Institute's head of metabolomics, Professor Peter Meikle and his team have identified plasma lipid biomarkers (fats in the blood) that improve upon traditional risk factors in predicting heart disease and stroke.
He says the revolutionary blood test is proposed to be trialled in Australia over the next 2-3 years as part of a broader personalised precision health program currently under development. Eventually a GP will be able to order this test in order to better assess a patient's risk of developing heart disease.
"The test was developed after a study looked at 10,000 samples to find the bio markers that will determine whether a person is at risk of having another heart attack," said Prof Meikle.
See here more details....